Abstract
Selegiline (1) [(-)-deprenyl] is used to treat patients with Parkinson’s disease. Nevertheless, in much higher doses it has beneficial effects in depression, and dementia of the aged patients. Selegiline (1) undergoes a complex metabolic pathway. Its major metabolites include (-)-desmethyldeprenyl (2), (-)-methamphetamine (3) and (-)-amphetamine (4), deprenyl-N-oxide (5) and formaldehyde (6) as a small metabolic fragment. In addition, more than 40 minor metabolites of selegiline (1) have also been either detected or proposed by investigators and researchers. This review analyses the pharmacological activity, generation pathway and the detection method of the major metabolites of selegiline (1).
Keywords: (-)-Amphetamine, (-)-desmethyldeprenyl, (-)-methamphetamine, deprenyl-N-oxide, formaldehyde, selegiline.
Current Medicinal Chemistry
Title:Metabolism of Selegiline [(-)-Deprenyl)]
Volume: 21 Issue: 13
Author(s): H. Kalasz, K. Magyar, E. Szoke, E. Adeghate, A. Adem, M.Y. Hasan, S.M. Nurulain and K. Takes
Affiliation:
Keywords: (-)-Amphetamine, (-)-desmethyldeprenyl, (-)-methamphetamine, deprenyl-N-oxide, formaldehyde, selegiline.
Abstract: Selegiline (1) [(-)-deprenyl] is used to treat patients with Parkinson’s disease. Nevertheless, in much higher doses it has beneficial effects in depression, and dementia of the aged patients. Selegiline (1) undergoes a complex metabolic pathway. Its major metabolites include (-)-desmethyldeprenyl (2), (-)-methamphetamine (3) and (-)-amphetamine (4), deprenyl-N-oxide (5) and formaldehyde (6) as a small metabolic fragment. In addition, more than 40 minor metabolites of selegiline (1) have also been either detected or proposed by investigators and researchers. This review analyses the pharmacological activity, generation pathway and the detection method of the major metabolites of selegiline (1).
Export Options
About this article
Cite this article as:
Kalasz H., Magyar K., Szoke E., Adeghate E., Adem A., Hasan M.Y., Nurulain S.M. and Takes K., Metabolism of Selegiline [(-)-Deprenyl)], Current Medicinal Chemistry 2014; 21 (13) . https://dx.doi.org/10.2174/0929867321666131218094352
DOI https://dx.doi.org/10.2174/0929867321666131218094352 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
PPARγ: Potential Therapeutic Target for Ailments Beyond Diabetes and its Natural Agonism
Current Drug Targets Targeting miRNAs for Drug Discovery: A New Paradigm
Current Molecular Medicine Ewing Sarcoma Family Tumors: Past, Present and Future Prospects
Current Cancer Therapy Reviews A Review on the Role of Phytosterols: New Insights Into Cardiovascular Risk
Current Pharmaceutical Design Chronic Inflammation and Oxidative Stress as a Major Cause of Age- Related Diseases and Cancer
Recent Patents on Inflammation & Allergy Drug Discovery Exploiting Microglial Functions for the Treatment of Glioblastoma
Current Cancer Drug Targets Promising Pharmacological, Molecular and Cellular Treatments of Autoimmune Hepatitis
Current Pharmaceutical Design Oncolytic Tanapoxvirus Expressing Interleukin-2 is Capable of Inducing the Regression of Human Melanoma Tumors in the Absence of T Cells
Current Cancer Drug Targets Bacteria and Bacterial Toxins as Therapeutic Agents for Solid Tumors
Current Cancer Drug Targets The Genetic Basis of Graves Disease
Current Genomics Drug-Loaded Nanocarriers in Tumor Targeted Drug Delivery
Current Biotechnology 3D-QSAR Studies on Flavone-8-acetic Acid Derivatives of Aminopeptidase N Inhibitors
Medicinal Chemistry Recent Advances in Synthesis and Identification of Cyclic Peptides for Bioapplications
Current Topics in Medicinal Chemistry Highlights in Peptide Nanoparticle Carriers Intended to Oral Diseases
Current Topics in Medicinal Chemistry The Fate of Nanoparticles In Vivo and the Strategy of Designing Stealth Nanoparticle for Drug Delivery
Current Drug Targets Susceptibility Risk Alleles of -238G/A, -308G/A and -1031T/C Promoter Polymorphisms of TNF-α Gene to Uterine Leiomyomas
Recent Advances in DNA & Gene Sequences (Discontinued) Papillary Tumor of the Pineal Region with Parinaud Syndrome: A Case Report
Current Medical Imaging Biomedical Applications of Accelerator Mass Spectrometry
Current Analytical Chemistry Stable Gastric Pentadecapeptide BPC 157: Novel Therapy in Gastrointestinal Tract
Current Pharmaceutical Design Smart Polymers and Their Role in Drug Delivery: A Review
Current Drug Therapy